Delivering AI-Powered

Real-World DataPersonalized MedicineObservational ResearchChart Abstraction

Solutions

Learn More

How We Help

Real-World Data and Insights

Digital Phenotyping and Personalized Medicine

Tech-Enabled Prospective and Retrospective Evidence Generation

Trusted by global companies

ISPOR Top 5%

Winner of "Best General Poster Research Presentation"

Winner of “Best General Poster Research Presentation” (collaboration with Lilly): Predictors of Low Disease Activity/ Remission Amongst Rheumatoid Arthritis Patients Experiencing Inadequate Response to Biologic/ Targeted Synthetic Disease-Modifying Antirheumatic Drugs

Frost & Sullivan: Life Sciences RWE Report

"2025: A top contender in growth and innovation"

OM1 is named a top contender in growth and innovation in the 2025 Frost Radar Life Sciences Real World Evidence Solutions Report.

ISPOR Poster (2025)

Poster: “Suicidal Ideation in Patients Treated with Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis”

Frost & Sullivan Award

"New Product Innovation"

OM1 is the recipient of the 2024 Frost & Sullivan Award in “New Product Innovation in North America RWE Analytics”

Poster Finalist

A Top 5% Finalist for ISPOR 2024 Research Presentation Awards in "AI & HEOR"

Poster: “Addressing Gaps in Real-World Data Sources through Automated Extraction of Psychiatric Comorbidities and Medication Side Effects from Clinical Notes”

News

21 August 2025

OM1 Rheumatoid Arthritis Dataset Rated High Quality as Cornerstone AI Partnership Speeds Future Quality Reviews

12 August 2025

OM1 Adds a Half Million Patients to Neurology Network, Strengthening Real-World Evidence Generation and Accelerating Innovation in Neurology

05 August 2025

OM1 Appoints Hunter Lane as Chief Product Officer

› See All News

Webinar

Redefining Evidence Generation: Innovative AI-Enabled Approaches for a New Era of Therapies

Join us and learn how Medical Affairs can build stronger evidence strategies, drive scientific exchange, and enable better communication with payers, providers, and regulators.

E-Book

Click to read PhenOM

This ebook explores powerful insights and analyses that leverage AI models and digital phenotyping, built on patient data from a network of over 300 million lives, to generate personalized insights around treatments, diagnosis, utilization, risks, and trials.

October 28-29 • Boston, MA • Booth #1

Join OM1 at the IMPACCT RWE in Boston, MA to explore real-world data and AI for research and personalized medicine.

IMPACCT 2025 banners